Oruka Therapeutics, Inc. (ticker: ORKA) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of ORKA's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. ORKA reported $0 in revenue and -$31.82M for the period ending 2024-06-30, with operating cash flow of -$23.58M. Cash and equivalents stood at $49.52M (down 40.7% year-over-year). Total assets of $504.48M exceed total liabilities of $17.76M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ORKA Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Oruka Therapeutics, Inc. (ORKA) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.